Orkla India Limited (ORKLAINDIA)
Outcome of Board Meeting
FY2026 results:
Standalone:
Revenue 24.6bn +5% y-y (23.0bn)
EBITDA 4.3bn +5% y-y (4.1bn)
EBITDA margin 17.5% (17.8%) -30 bps y-y
PAT 2.8bn +4% y-y (2.7bn)
Consolidated:
Revenue 25.1bn +5% y-y (23.9bn)
EBITDA 4.0bn +5% y-y (3.8bn)
EBITDA margin 16.1% (16.0%) +10 bps y-y
PAT 2.9bn +5% y-y (2.7bn)
Q1FY27 results (unaudited):
Standalone:
Revenue 6.4bn +10% y-y (5.9bn)
EBITDA 1.2bn +10% y-y (1.1bn)
EBITDA margin 18.0% (17.8%) +20 bps y-y
PAT 0.9bn +11% y-y (0.8bn)
Consolidated:
Revenue 6.6bn +10% y-y (6.0bn)
EBITDA 1.2bn +9% y-y (1.1bn)
EBITDA margin 17.0% (16.7%) +30 bps y-y
PAT 0.9bn +11% y-y (0.8bn)
Commentary: Exceptional item of Rs 15 million credit in Q1FY27 relates to reversal of estimated gratuity liability following new Labour Codes.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 ORKLAINDIA — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add ORKLAINDIA to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Orkla India Limited
Important.
The summary above is generated automatically from Orkla India Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.